Zobrazeno 1 - 10
of 225
pro vyhledávání: '"Pastore-Celentano L"'
Publikováno v:
In Clinical Microbiology and Infection May 2014 20 Supplement 5:2-6
Autor:
Hanquet G, Krizova P, Dalby T, Ladhani SN, Nuorti JP, Danis K, Mereckiene J, Knol MJ, Winje BA, Ciruela P, de Miguel S, Portillo ME, MacDonald L, Morfeldt E, Kozakova J, Valentiner-Branth P, Fry NK, Rinta-Kokko H, Varon E, Corcoran M, van der Ende A, Vestrheim DF, Munoz-Almagro C, Sanz JC, Castilla J, Smith A, Henriques-Normark B, Colzani E, Pastore-Celentano L, Savulescu C, SpIDnet group1
Publikováno v:
EMERGING INFECTIOUS DISEASES
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
We evaluated invasive pneumococcal disease (IPD) during 8 years of infant pneumococcal conjugate vaccine (PCV) programs using 10-valent (PCV10) and 13-valent (PCV13) vaccines in 10 countries in Europe. IPD incidence declined during 2011-2014 but incr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::540e857fdb555ccf07a4a3b204cec6a0
http://fundanet.fsjd.org/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=20494
http://fundanet.fsjd.org/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=20494
Autor:
Savulescu C; Epiconcept, Paris, France., Krizova P; National Institute of Public Health, Prague, Czech Republic., Valentiner-Branth P; Statens Serum Institut, Copenhagen, Denmark., Ladhani S; Public Health England, London, United Kingdom., Rinta-Kokko H; National Institute for Health and Welfare, Helsinki, Finland., Levy C; ACTIV, Créteil, France., Mereckiene J; Health Protection Surveillance Centre Dublin, Ireland., Knol M; National Institute for Public Health and the Environment, Bilthoven, the Netherlands., Winje BA; Norwegian Institute of Public Health, Oslo, Norway., Ciruela P; Health Agency of Catalunya, Barcelona, Spain; CIBER Epidemiología y Salud Pública, Madrid, Spain., de Miguel S; General Directorate of Public Health Madrid, Spain., Guevara M; Public Health Institute of Navarra - IdiSNA, Pamplona, Spain; CIBER Epidemiología y Salud Pública, Madrid, Spain., MacDonald L; Public Health Scotland, Glasgow, Scotland, UK., Kozakova J; National Institute of Public Health, Prague, Czech Republic., Slotved HC; Statens Serum Institut, Copenhagen, Denmark., Fry NK; Public Health England, London, United Kingdom., Pekka Nuorti J; National Institute for Health and Welfare, Helsinki, Finland; Tampere University, Tampere, Finland., Danis K; Santé publique France, the National Public Health Institute, Saint-Maurice, France., Corcoran M; Temple Street Children's University Hospital, Irish Pneumococcal Reference Laboratory, Dublin, Ireland., van der Ende A; Academic Medical Centre, National Reference Laboratory for Bacterial Meningitis, Amsterdam, the Netherlands., Vestrheim DF; Norwegian Institute of Public Health, Oslo, Norway., Munoz-Almagro C; Hospital Sant Joan de Déu, and International University of Catalunya, Barcelona, Spain; CIBER Epidemiología y Salud Pública, Madrid, Spain., Sanz JC; General Directorate of Public Health Madrid, Spain., Castilla J; Public Health Institute of Navarra - IdiSNA, Pamplona, Spain; CIBER Epidemiología y Salud Pública, Madrid, Spain., Smith A; Bacterial Respiratory Infection Service, Scottish Microbiology Reference Laboratory, Glasgow Royal Infirmary & MVLS, University of Glasgow, Glasgow, Scotland, UK., Colzani E; European Centre for Disease Prevention and Control, Stockholm, Sweden., Pastore Celentano L; European Centre for Disease Prevention and Control, Stockholm, Sweden., Hanquet G; Epiconcept, Paris, France; Antwerp university, Antwerp, Belgium. Electronic address: ghanquet@skynet.be.
Publikováno v:
Vaccine [Vaccine] 2022 Jun 23; Vol. 40 (29), pp. 3963-3974. Date of Electronic Publication: 2022 May 28.
Autor:
Kissling E; Epiconcept, Paris, France., Hooiveld M; Nivel, Utrecht, the Netherlands., Martínez-Baz I; Instituto de Salud Pública de Navarra - IdiSNA, Pamplona, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain., Mazagatos C; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.; National Centre for Epidemiology, Institute of Health Carlos III, Madrid, Spain., William N; Public Health Scotland, Glasgow, United Kingdom., Vilcu AM; INSERM, Sorbonne Université, Institut Pierre Louis d'épidémiologie et de Santé Publique (IPLESP UMRS 1136), Paris, France., Kooijman MN; National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands., Ilić M; Croatian Institute of Public Health, Zagreb, Croatia., Domegan L; Health Service Executive-Health Protection Surveillance Centre, Dublin, Ireland., Machado A; Instituto Nacional de Saúde Dr. Ricardo Jorge, Lisbon, Portugal., de Lusignan S; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.; Royal College of General Practitioners Research and Surveillance Centre, London, United Kingdom., Lazar M; 'Cantacuzino' National Military Medical Institute for Research and Development, Bucharest, Romania., Meijer A; National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands., Brytting M; The Public Health Agency of Sweden, Stockholm, Sweden., Casado I; Instituto de Salud Pública de Navarra - IdiSNA, Pamplona, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain., Larrauri A; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.; National Centre for Epidemiology, Institute of Health Carlos III, Madrid, Spain., Murray JK; Public Health Scotland, Glasgow, United Kingdom., Behillil S; Unité de Génétique Moléculaire des Virus à ARN, UMR 3569 CNRS, Université Paris Diderot SPC, Institut Pasteur, Paris, France.; CNR des virus des infections respiratoires, Institut Pasteur, Paris, France., de Gier B; National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands., Mlinarić I; Croatian Institute of Public Health, Zagreb, Croatia., O'Donnell J; Health Service Executive-Health Protection Surveillance Centre, Dublin, Ireland., Rodrigues AP; Instituto Nacional de Saúde Dr. Ricardo Jorge, Lisbon, Portugal., Tsang R; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.; Royal College of General Practitioners Research and Surveillance Centre, London, United Kingdom., Timnea O; 'Cantacuzino' National Military Medical Institute for Research and Development, Bucharest, Romania., de Lange M; National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands., Riess M; The Public Health Agency of Sweden, Stockholm, Sweden., Castilla J; Instituto de Salud Pública de Navarra - IdiSNA, Pamplona, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain., Pozo F; National Centre for Microbiology, Institute of Health Carlos III, Madrid, Spain., Hamilton M; Public Health Scotland, Glasgow, United Kingdom., Falchi A; Laboratoire de Virologie, Université de Corse-Inserm, Corte, France., Knol MJ; National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands., Kurečić Filipović S; Croatian Institute of Public Health, Zagreb, Croatia., Dunford L; National Virus Reference Laboratory, University College Dublin, Dublin, Ireland., Guiomar R; Instituto Nacional de Saúde Dr. Ricardo Jorge, Lisbon, Portugal., Cogdale J; UK Health Security Agency, United Kingdom., Cherciu C; 'Cantacuzino' National Military Medical Institute for Research and Development, Bucharest, Romania., Jansen T; Nivel, Utrecht, the Netherlands., Enkirch T; The Public Health Agency of Sweden, Stockholm, Sweden., Basile L; Subdirección General de Vigilancia y Respuesta a Emergencias de Salud Pública, Agencia de Salud Pública, Catalunya, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain., Connell J; National Virus Reference Laboratory, University College Dublin, Dublin, Ireland., Gomez V; Instituto Nacional de Saúde Dr. Ricardo Jorge, Lisbon, Portugal., Sandonis Martín V; National Centre for Microbiology, Institute of Health Carlos III, Madrid, Spain., Bacci S; European Centre for Disease Prevention and Control, Stockholm, Sweden., Rose AM; Epiconcept, Paris, France., Pastore Celentano L; European Centre for Disease Prevention and Control, Stockholm, Sweden., Valenciano M; Epiconcept, Paris, France.
Publikováno v:
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin [Euro Surveill] 2022 May; Vol. 27 (21).
Autor:
Savulescu, Camelia, Valentiner-Branth, P., Mereckiene, J., Winje, B.A., Ciruela, P., Latasa, P., Guevara, M., Carragher, Raymond Bernard, Dalby, T., Corcoran, M., Vestrheim, D.F., Munoz-Almagro, C., Sanz, J.C., Castilla, J., Smith, A., Colzani, E., Pastore-Celentano, L., Hanquet, G.
Publikováno v:
11th International Symposium on Pneumococci and Pneumococcal Diseases
Background and Aims: We measured the effectiveness of 23-valent pneumococcal polysaccharidic vaccine(PPV23) against invasive pneumococcal disease (IPD) in 65+ year-olds, pooling surveillance data from seven European sites. PPV23 vaccination is recomm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::a3a4931285c906d8b0e6660920ebd73c
https://strathprints.strath.ac.uk/64158/1/Savulescu_etal_ISPPD_2018_Effectiveness_of_the_23_valent_pneumococcal_polysaccharide_vaccine_against_Invasive_Pneumococcal_Disease.pdf
https://strathprints.strath.ac.uk/64158/1/Savulescu_etal_ISPPD_2018_Effectiveness_of_the_23_valent_pneumococcal_polysaccharide_vaccine_against_Invasive_Pneumococcal_Disease.pdf
Autor:
Colzani E; European Centre for Disease Prevention and Control, Stockholm, Sweden., Johansen K; European Centre for Disease Prevention and Control, Stockholm, Sweden., Johnson H; European Centre for Disease Prevention and Control, Stockholm, Sweden., Pastore Celentano L; European Centre for Disease Prevention and Control, Stockholm, Sweden.
Publikováno v:
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin [Euro Surveill] 2021 Dec; Vol. 26 (50).
Autor:
Kanan, Mohammed1 ii_kanan101@outlook.com, Alotaibi, Nawaf2, Munif, Mohammed3, Alghumuy, Anas4, Alsayed, Mayar4, Almanjumi, Sahar5, Alnemari, Joud5, Altwairqi, Wasan5, Marwai, Abdulrahman6, Alfaifi, Khalid7, Alkharisi, Ron7, Madkhali, Hassan6, Alotaibi, Samar8, Asiri, Shuruq9
Publikováno v:
Tropical Journal of Pharmaceutical Research. Oct2024, Vol. 23 Issue 10, p1769-1777. 9p.
Autor:
Derrough, T., Olsson, K., Gianfredi, V., Simondon, F., Heijbel, H., Danielsson, N., Kramarz, P., Pastore-Celentano, L.
Publikováno v:
Eurosurveillance (15607917); 4/27/2017, Vol. 22 Issue 17, p10-20, 11p, 3 Charts, 1 Map
Autor:
Navarro Torné, A, Dias, Jg, Quinten, C, Hruba, F, Busana, Mc, Lopalco, PIETRO LUIGI, Gauci, Aj, Pastore Celentano, L, ECDC country experts for pneumococcal disease
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3728::db0b2ede20bef56f960ae7375bd2f67e
http://hdl.handle.net/11568/799955
http://hdl.handle.net/11568/799955
Autor:
Díez-Domingo, Javier1,2 (AUTHOR), Simkó, Róbert3 (AUTHOR), Icardi, Giancarlo4 (AUTHOR), Chong, Chan Poh5 (AUTHOR), Zocchetti, Céline6 (AUTHOR), Syrkina, Olga7 (AUTHOR), Bchir, Siham8 (AUTHOR), Bertrand-Gerentes, Isabelle6 (AUTHOR) isabelle.bertrand-gerentes@sanofi.com
Publikováno v:
Infectious Diseases & Therapy. Aug2024, Vol. 13 Issue 8, p1835-1859. 25p.